Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, (including amendments thereto), we wish to inform you that the trading window for ....
Awaiting price reaction for this filing.
Garodia Chemicals Ltd has informed BSE that the trading window for dealing in its equity shares will remain closed from January 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended December 31, 2025. The closure applies to all designated persons and their immediate relatives, as required under SEBI's Prohibition of Insider Trading Regulations, 2015. Designated persons have been asked not to trade in the company's securities during this restricted period. The company also stated that the date of the board meeting to approve the Q3 results will be communicated later. The intimation is signed by Managing Director Ravindra Subhash Salunkhe.
This is a routine compliance filing ahead of quarterly results and has no direct impact on the stock price. It signals that the company's Q3 FY26 earnings announcement is expected sometime in January 2026, which investors should watch for as the next potential catalyst.